Calcium gluconate
General
- Type: Electrolyte
- Dosage Forms: injectable solution, tablet, capsule
- Dosage Strenths: injectable solution: 100mg/mL; tablet: 50, 500, 650mg; capsule: 500mg
- Routes of Administration: PO, IV
- Common Trade Names:
Adult Dosing
- Calcium Supplementation
- 19-50 years old: 1000mg/day PO (divided q8-12hr)
- >50 years old: 1200mg/day PO (divided q8-12hr)
- Pregnant or breastfeeding patient: 1000mg/day PO (divided q8-12hr)
- Hypocalcemia
- Mild (Calcium 1-1.2 mmol/L)
- 1-3 g/day PO in divided doses
- 1-2 g IV over 2 hours
- Severe (Calcium < 1 mmol/L)
- without seizure or tetany: 0.5mg/kg/hr IV, may be increased to 2mg/kg/hr
- Hypocalcemic tetany:
- 100-300mg elemental calcium (~3g calcium gluconate) IV over 5-10 min
- Followed by continuous IV infusion at 0.5mg/kg/hr
- Mild (Calcium 1-1.2 mmol/L)
- Calcium channel blocker toxicity: 3g IV (30-60mL of 10% soln)
- Hyperkalemia: Give 10ml of a 10% solution over 10 mins
Pediatric Dosing
- Hypocalcemia
- Children: 200 to 500 mg IV (slow injection)
- Infants: up to 200 mg IV (slow injection
- Seizure due to hypocalcemia: 10% calcium gluconate IV 0.3 mL/kg over 5-10min
Special Populations
- Pregnancy Rating: C
- Lactation risk: Use with caution
- Renal Dosing:
- CrCl less than 25 mL/min, base dosing on serum calcium levels
- ESRD: if on HD, may need dose reduction
- Hepatic Dosing: No adjustment
Contraindications
- Hypersensitivity
- Hypercalcemia
- Ventricular fibrillation
- Digoxin toxicity (known or suspected)
- Neonates receiving ceftriaxone sodium injection
Adverse Reactions
Serious
- Bradycardia, vasodilation, hypotension, MI, cardiac arrest
- Tissue necrosis (due to extravasation)
- Urolithiasis
- Prostate cancer
Common
- Constipation, abdominal bloating, flatulence
- Headache
Pharmacology
- Half-life:
- Metabolism:
- Absorption requires Vitamin D
- Absorption is increased with acidic condition; thus, administer 1-2 hr after meals
- ~45% protein bound (primarily to albumin)
- Excretion: feces as unabsorbed calcium salt (80%), urine (20%)
Mechanism of Action
- Bone mineral component; cofactor in enzymatic reactions, essential for neurotransmission, muscle contraction, and many signal transduction pathways.
Comments
See Also
References
This article is issued from
Wikem.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.